The patient controlled analgesia pumps market size valued for $277.67 million in 2021 and is estimated to reach $407.89 million by 2031, exhibiting a CAGR of 3.9% from 2022 to 2031.
Patient-controlled analgesia (PCA) is an effective pain management technique that offers the patient control over their pain. These pumps deliver opioid painkillers such hydromorphone, fentanyl, and morphine. The pump is attached to an intravenous (IV) line, which is a small, flexible tube inserted into a vein. Normally, this medication is administered when the button is pressed. These pumps are medical devices that deliver the medications into a patient’s body in controlled amounts. Analgesic pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home. The applications of these analgesic pumps for delivery of medications such as morphine, fentanyl and hydromorphone. The PCA pump have the advantages such as safe to use, patient satisfaction, less sedation, reduced medication, and the nursing team is informed by an alert when the pump is empty.
PCA is equipped with a computerized pump, which is often used by patients recovering from surgery. It is employed for post-operative management. It is a method of pain control that provides patients with the power to control their pain. In addition, PCA is beneficial for patients who find difficulty in consuming medication by mouth. In some cases, the dose is set and an additional dose can be administered by patients themselves just by pressing a button. The patient-controlled analgesia can be administered by various routes, including oral, intravenous, epidural, inhaled, nasal spray, and transcutaneous.
Patient controlled analgesia pumps are used to treat acute, chronic, postoperative, and labor pain, particularly in individuals who are unable to receive oral medications. In cases of acute pain in which the initial opioid dose in urgent care was insufficient to relieve pain thus, patient-controlled analgesia pumps can be useful. Some examples of common cases include burns, trauma, pancreatitis, and vaso-occlusive pain crises.
The growth of global patient controlled analgesia pumps market is majorly driven by increase in demand for analgesic pumps to relieve the pain such as cancer pain, orthopedic, and sickle cell crises pain, rise in number of surgical procedures which requires the analgesic pumps. However, lack of knowledge regarding advanced patient controlled analgesic pumps in emerging countries and regulations for product approval hinders the market growth. Conversely, increase in demand for patient controlled analgesic pumps and rise in technological advancements in analgesic pumps are anticipated to provide lucrative opportunities to the market players. The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are safer, more efficient, and standardized. In addition, the introduction of advanced PCA pumps provides the lucrative growth opportunities for the market.
Factors such as surge in geriatric population, rise in prevalence of chronic pain, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cancer, or other ailments is likely to have a positive impact on the market growth. Rise in incidence of diseases such as cancer, sickle cell disease, and orthopedics has led to an increase in demand for patient controlled analgesic pump devices. For instance, according to the Centers for Disease Control and Prevention (CDC), estimated that approximately 100,000 Americans affected with sickle cell disease in May 2022. Thus, rise in prevalence of sickle cell disease has increased the uptake for PCA pumps and thus drives the market growth.
The global patient controlled analgesia pumps market is segmented into type, application, end user, and region. By type, the market is categorized into electronic & wireless and mechanical. On the basis of application, the market is segregated into oncology & hematology, gastroenterology, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global patient controlled analgesia pumps market are Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd.
Patient-controlled analgesia (PCA) is an effective pain management technique that offers the patient control over their pain. These pumps deliver opioid painkillers such hydromorphone, fentanyl, and morphine. The pump is attached to an intravenous (IV) line, which is a small, flexible tube inserted into a vein. Normally, this medication is administered when the button is pressed. These pumps are medical devices that deliver the medications into a patient’s body in controlled amounts. Analgesic pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home. The applications of these analgesic pumps for delivery of medications such as morphine, fentanyl and hydromorphone. The PCA pump have the advantages such as safe to use, patient satisfaction, less sedation, reduced medication, and the nursing team is informed by an alert when the pump is empty.
PCA is equipped with a computerized pump, which is often used by patients recovering from surgery. It is employed for post-operative management. It is a method of pain control that provides patients with the power to control their pain. In addition, PCA is beneficial for patients who find difficulty in consuming medication by mouth. In some cases, the dose is set and an additional dose can be administered by patients themselves just by pressing a button. The patient-controlled analgesia can be administered by various routes, including oral, intravenous, epidural, inhaled, nasal spray, and transcutaneous.
Patient controlled analgesia pumps are used to treat acute, chronic, postoperative, and labor pain, particularly in individuals who are unable to receive oral medications. In cases of acute pain in which the initial opioid dose in urgent care was insufficient to relieve pain thus, patient-controlled analgesia pumps can be useful. Some examples of common cases include burns, trauma, pancreatitis, and vaso-occlusive pain crises.
The growth of global patient controlled analgesia pumps market is majorly driven by increase in demand for analgesic pumps to relieve the pain such as cancer pain, orthopedic, and sickle cell crises pain, rise in number of surgical procedures which requires the analgesic pumps. However, lack of knowledge regarding advanced patient controlled analgesic pumps in emerging countries and regulations for product approval hinders the market growth. Conversely, increase in demand for patient controlled analgesic pumps and rise in technological advancements in analgesic pumps are anticipated to provide lucrative opportunities to the market players. The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are safer, more efficient, and standardized. In addition, the introduction of advanced PCA pumps provides the lucrative growth opportunities for the market.
Factors such as surge in geriatric population, rise in prevalence of chronic pain, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cancer, or other ailments is likely to have a positive impact on the market growth. Rise in incidence of diseases such as cancer, sickle cell disease, and orthopedics has led to an increase in demand for patient controlled analgesic pump devices. For instance, according to the Centers for Disease Control and Prevention (CDC), estimated that approximately 100,000 Americans affected with sickle cell disease in May 2022. Thus, rise in prevalence of sickle cell disease has increased the uptake for PCA pumps and thus drives the market growth.
The global patient controlled analgesia pumps market is segmented into type, application, end user, and region. By type, the market is categorized into electronic & wireless and mechanical. On the basis of application, the market is segregated into oncology & hematology, gastroenterology, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global patient controlled analgesia pumps market are Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient controlled analgesia pumps market analysis from 2021 to 2031 to identify the prevailing patient controlled analgesia pumps market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the patient controlled analgesia pumps market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global patient controlled analgesia pumps market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By Type
- Electronic and Wireless
- Mechanical
By Application
- Oncology and hematology
- Gastroenterology
By End user
- Hospitals
- Ambulatory surgical centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Ace-medical
- B. Braun SE
- ICU Medical, Inc.
- SCW Medicath Ltd
- Changzhou Medical Bioengineering Co., Ltd.
- Arcomed AG
- Becton, Dickinson and Company
- Henan Tuoren Medical Device Co., Ltd.
- Fresenius SE and Co. KGaA
- Micrel Medical Devices SA
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in cases of chronic pain diseases
3.4.1.2. Technological advancements in analgesic pumps
3.4.1.3. Increase in number of surgeries
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding analgesia pumps
3.4.2.2. Stringent government regulations
3.4.3. Opportunities
3.4.3.1. Lucrative growth opportunities in developing countries
3.4.3.2. Development in analgesic pumps
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Electronic and Wireless
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Mechanical
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology and hematology
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Gastroenterology
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End user
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End user
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End user
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End user
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End user
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End user
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End user
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End user
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Ace-medical
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Arcomed AG
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. B. Braun SE
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Becton, Dickinson and Company
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Henan Tuoren Medical Device Co., Ltd.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. ICU Medical, Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Micrel Medical Devices SA
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Fresenius SE and Co. KGaA
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Changzhou Medical Bioengineering Co., Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. SCW Medicath Ltd
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
List of Tables
Table 01. Global Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 02. Patient Controlled Analgesia Pumps Market for Electronic and Wireless, by Region, 2021-2031 (Revenue, $Million)
Table 03. Patient Controlled Analgesia Pumps Market for Mechanical, by Region, 2021-2031 (Revenue, $Million)
Table 04. Global Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 05. Patient Controlled Analgesia Pumps Market for Oncology and Hematology, by Region, 2021-2031 (Revenue, $Million)
Table 06. Patient Controlled Analgesia Pumps Market for Gastroenterology, by Region, 2021-2031 (Revenue, $Million)
Table 07. Patient Controlled Analgesia Pumps Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 08. Global Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 09. Patient Controlled Analgesia Pumps Market for Hospitals, by Region, 2021-2031 (Revenue, $Million)
Table 10. Patient Controlled Analgesia Pumps Market for Ambulatory Surgical Centers, by Region, 2021-2031 (Revenue, $Million)
Table 11. Patient Controlled Analgesia Pumps Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 12. Patient Controlled Analgesia Pumps Market, by Region, 2021-2031 (Revenue, $Million)
Table 13. North America Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 14. North America Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 15. North America Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 16. North America Patient Controlled Analgesia Pumps Market, by Country, 2021-2031 (Revenue, $Million)
Table 17. U.S. Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 18. U.S. Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 19. U.S. Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 20. Canada Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 21. Canada Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 22. Canada Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 23. Mexico Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 24. Mexico Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 25. Mexico Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 26. Europe Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 27. Europe Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 28. Europe Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 29. Europe Patient Controlled Analgesia Pumps Market, by Country, 2021-2031 (Revenue, $Million)
Table 30. Germany Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 31. Germany Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 32. Germany Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 33. France Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 34. France Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 35. France Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 36. UK Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 37. UK Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 38. UK Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 39. Italy Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 40. Italy Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 41. Italy Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 42. Spain Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 43. Spain Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 44. Spain Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 45. Rest of Europe Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 46. Rest of Europe Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 47. Rest of Europe Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 48. Asia-Pacific Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 49. Asia-Pacific Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 51. Asia-Pacific Patient Controlled Analgesia Pumps Market, by Country, 2021-2031 (Revenue, $Million)
Table 52. Japan Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 53. Japan Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 54. Japan Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 55. China Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 56. China Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 57. China Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 58. India Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 59. India Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 60. India Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 61. Australia Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 62. Australia Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 63. Australia Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 64. South Korea Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 65. South Korea Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 66. South Korea Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 67. Rest of Asia-Pacific Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 68. Rest of Asia-Pacific Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 69. Rest of Asia-Pacific Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 70. LAMEA Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 71. LAMEA Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 73. LAMEA Patient Controlled Analgesia Pumps Market, by Country, 2021-2031 (Revenue, $Million)
Table 74. Brazil Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 75. Brazil Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 76. Brazil Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 77. Saudi Arabia Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 78. Saudi Arabia Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 79. Saudi Arabia Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 80. South Africa Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 81. South Africa Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 82. South Africa Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 83. Rest of LAMEA Patient Controlled Analgesia Pumps Market, by Type, 2021-2031 (Revenue, $Million)
Table 84. Rest of LAMEA Patient Controlled Analgesia Pumps Market, by Application, 2021-2031 (Revenue, $Million)
Table 85. Rest of LAMEA Patient Controlled Analgesia Pumps Market, by End-user, 2021-2031 (Revenue, $Million)
Table 86. Ace-Medical: Key Executives
Table 87. Ace-Medical: Company Snapshot
Table 88. Ace-Medical: Product Segments
Table 89. Ace-Medical: Product Portfolio
Table 90. Arcomed AG: Key Executives
Table 91. Arcomed AG: Company Snapshot
Table 92. Arcomed AG: Product Segments
Table 93. Arcomed AG: Product Portfolio
Table 94. B. Braun SE: Key Executives
Table 95. B. Braun SE: Company Snapshot
Table 96. B. Braun SE: Product Segments
Table 97. B. Braun SE: Product Portfolio
Table 98. Becton, Dickinson and Company: Key Executives
Table 99. Becton, Dickinson and Company: Company Snapshot
Table 100. Becton, Dickinson and Company: Product Segments
Table 101. Becton, Dickinson and Company: Product Portfolio
Table 102. Henan Tuoren Medical Device Co. Ltd.: Key Executives
Table 103. Henan Tuoren Medical Device Co. Ltd.: Company Snapshot
Table 104. Henan Tuoren Medical Device Co. Ltd.: Product Segments
Table 105. Henan Tuoren Medical Device Co. Ltd.: Product Portfolio
Table 106. Icu Medical, Inc.: Key Executives
Table 107. Icu Medical, Inc.: Company Snapshot
Table 108. Icu Medical, Inc.: Product Segments
Table 109. Icu Medical, Inc.: Product Portfolio
Table 110. Icu Medical, Inc.: Key Strategies
Table 111. Micrel Medical Devices SA: Key Executives
Table 112. Micrel Medical Devices SA: Company Snapshot
Table 113. Micrel Medical Devices SA: Product Segments
Table 114. Micrel Medical Devices SA: Product Portfolio
Table 115. Fresenius SE and Co. KGaA: Key Executives
Table 116. Fresenius SE and Co. KGaA: Company Snapshot
Table 117. Fresenius SE and Co. KGaA: Product Segments
Table 118. Fresenius SE and Co. KGaA: Product Portfolio
Table 119. Changzhou Medical Bioengineering Co. Ltd.: Key Executives
Table 120. Changzhou Medical Bioengineering Co. Ltd.: Company Snapshot
Table 121. Changzhou Medical Bioengineering Co. Ltd.: Product Segments
Table 122. Changzhou Medical Bioengineering Co. Ltd.: Product Portfolio
Table 123. Scw Medicath Ltd.: Key Executives
Table 124. Scw Medicath Ltd.: Company Snapshot
Table 125. Scw Medicath Ltd.: Product Segments
Table 126. Scw Medicath Ltd.: Product Portfolio
List of Figures
Figure 01. Patient Controlled Analgesia Pumps Market, 2021-2031
Figure 02. Segmentation of Patient Controlled Analgesia Pumps Market, 2021-2031
Figure 03. Top Investment Pockets in Patient Controlled Analgesia Pumps Market (2022-2031)
Figure 04. Moderate Bargaining Power of Suppliers
Figure 05. Moderate Bargaining Power of Buyers
Figure 06. Moderate Threat of Substitutes
Figure 07. Moderate Threat of New Entrants
Figure 08. Moderate Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalpatient Controlled Analgesia Pumps Market
Figure 10. Patient Controlled Analgesia Pumps Market, by Type, 2021(%)
Figure 11. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Electronic and Wireless, by Country 2021-2031(%)
Figure 12. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Mechanical, by Country 2021-2031(%)
Figure 13. Patient Controlled Analgesia Pumps Market, by Application, 2021(%)
Figure 14. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Oncology and Hematology, by Country 2021-2031(%)
Figure 15. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Gastroenterology, by Country 2021-2031(%)
Figure 16. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Others, by Country 2021-2031(%)
Figure 17. Patient Controlled Analgesia Pumps Market, by End-user, 2021(%)
Figure 18. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Hospitals, by Country 2021-2031(%)
Figure 19. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Ambulatory Surgical Centers, by Country 2021-2031(%)
Figure 20. Comparative Share Analysis of Patient Controlled Analgesia Pumps Market for Others, by Country 2021-2031(%)
Figure 21. Patient Controlled Analgesia Pumps Market by Region, 2021
Figure 22. U.S. Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 23. Canada Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 24. Mexico Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 25. Germany Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 26. France Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 27. UK Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 28. Italy Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 29. Spain Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 30. Rest of Europe Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 31. Japan Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 32. China Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 33. India Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 34. Australia Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 35. South Korea Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 36. Rest of Asia-Pacific Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 37. Brazil Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 38. Saudi Arabia Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 39. South Africa Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 40. Rest of LAMEA Patient Controlled Analgesia Pumps Market, 2021-2031 ($Million)
Figure 41. Top Winning Strategies, by Year
Figure 42. Top Winning Strategies, by Development
Figure 43. Top Winning Strategies, by Company
Figure 44. Product Mapping of Top 10 Players
Figure 45. Competitive Dashboard
Figure 46. Competitive Heatmap: Patient Controlled Analgesia Pumps Market
Figure 47. Top Player Positioning, 2021
Figure 48. B. Braun SE: Net Sales, 2019-2021 ($Million)
Figure 49. B. Braun SE: Revenue Share by Segment, 2021 (%)
Figure 50. B. Braun SE: Revenue Share by Region, 2021 (%)
Figure 51. Becton, Dickinson and Company: Net Revenue, 2019-2021 ($Million)
Figure 52. Becton, Dickinson and Company: Revenue Share by Segment, 2021 (%)
Figure 53. Becton, Dickinson and Company: Revenue Share by Region, 2021 (%)
Figure 54. Icu Medical, Inc.: Net Revenue, 2019-2021 ($Million)
Figure 55. Icu Medical, Inc.: Revenue Share by Segment, 2021 (%)
Figure 56. Icu Medical, Inc.: Revenue Share by Region, 2021 (%)
Figure 57. Fresenius SE and Co. KGaA: Net Sales, 2019-2021 ($Million)
Figure 58. Fresenius SE and Co. KGaA: Revenue Share by Segment, 2021 (%)
Figure 59. Fresenius SE and Co. KGaA: Revenue Share by Region, 2021 (%)
Executive Summary
According to the report titled, 'Patient Controlled Analgesia Pumps Market,' the patient controlled analgesia pumps market size was valued at $277.67 million in 2021, and is estimated to reach $407.9 million by 2031, growing at a CAGR of 3.9% from 2022 to 2031.Patient-controlled analgesia is useful in a variety of clinical settings, including the management of burns, cancer, sickle cell crises, and postoperative pain. Analgesic pumps deliver the analgesics medication to manage the pain. Analgesic pumps enable the patients to give the proper analgesic doses, when necessary, which has been shown to reduce the related anxiety. These pumps allow the patients to self-administer a set dose of pain medication through a small computerized device, which is attached to an intravenous (IV) line. PCA pumps are commonly used in hospitals and other healthcare settings to manage pain including surgery or injury, as well as for the treatment of chronic pain conditions.
Key factors driving the growth of the patient controlled analgesia market include the rise in chronic pain conditions and the need for effective pain management and increase in number of surgical procedures. Chronic pain is one of the ten most common diseases in the world. In addition, there is a rise in cases of chronic pain which requires the analgesics medication to relieve the pain. This has led to rise in the demand for patient-controlled analgesia pumps. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2019, around 20.4% of adults had chronic pain.
PCA pumps offer patients greater control over their pain management, allowing for faster and more effective pain relief, leading to improved outcomes and patient satisfaction. In addition, development of advanced PCA pumps with features such as programmable dosing, increased safety features, and remote monitoring capabilities are increasing their popularity. For instance, Volumed µVP7000 and Syramed µSP6000 are products of Arcomed AG company, which has various features such as convenient patient bolus button, preset programs for enhanced safety and convenience and password and locking mechanism.
Furthermore, government initiatives and regulations promoting the use of patient-controlled analgesia and reimbursement policies for these devices are contributing to market growth. Moreover, the increase in demand for home healthcare and the trend towards patient-centered care is driving the growth of the patient controlled analgesia pumps market, as these pumps can be used in a home setting. In contrast, lack of advanced healthcare infrastructure in emerging countries, and lack of awareness regarding advanced analgesia pump limits the market growth.
Moreover, rise in technological advancements in analgesic pumps which drive the market growth. Companies are working to provide multidirectional interoperability, secure patient and instrument data, and integrate complete medication libraries into pumps (better electronic health record management). These are expected to enhance the administration of medication in various care settings.
The market also offers growth opportunities to the key players in the market. There is a significant opportunity for manufacturers to develop new and innovative PCA pumps with advanced features, such as improved patient safety and greater ease of use, to meet the growing demand for effective pain management. In addition, increase in adoption of remote patient monitoring is also presenting opportunities for the growth of the patient controlled analgesic pumps market, as these pumps can be monitored remotely for improved patient safety and convenience. The increase in demand for minimally invasive procedures and the use of PCA pumps for post-operative pain management is presenting growth opportunities for the patient controlled analgesia pumps market.
The patient controlled analgesia pumps market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into electronic & wireless and mechanical.
On the basis of application, it is fragmented into oncology & hematology, gastroenterology, and others. On the basis of end user, it is segmented into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd.
Key Market Insights
- By type, the electronic & wireless segment was the highest revenue contributor to the market and is estimated to reach $312.68 million by 2031, with a CAGR of 4.1%.
- By application, the oncology & hematology segment dominated the global market in 2021.
- Based on end user, the others segment was the largest revenue contributor to the market with a CAGR of 4.4% during the forecast period.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
- Ace-medical
- B. Braun SE
- ICU Medical, Inc.
- SCW Medicath Ltd
- Changzhou Medical Bioengineering Co., Ltd.
- Arcomed AG
- Becton, Dickinson and Company
- Henan Tuoren Medical Device Co., Ltd.
- Fresenius SE and Co. KGaA
- Micrel Medical Devices SA
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
